Responses
Clinical/translational cancer immunotherapy
Original research
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.